Induction of interleukin‐6 by interferon alfa and its abrogation by a serine protease inhibitor in patients with chronic hepatitis C
N Ito, S Kawata, S Tamura, S Kiso, H Tsushima, Y Maeda, E Yamasaki, T Igura, Y Matsuzawa – 1 April 1996 – We investigated short‐term alterations in plasma interleukin‐6 (IL‐6), interleukin‐1β (IL‐1β), and tumor necrosis factor α (TNF‐α) levels induced by interferon alfa (IFN‐α) injection in 18 patients with chronic hepatitis C. A single intramuscular injection of human recombinant IFN‐α 2a (6 million units [MU]) significantly increased the plasma IL‐6 level 6 hours after the injection (P < .05). On the other hand, the IFN‐α injection did not affect the plasma TNF‐α and IL‐lβ levels.